Lung matrix homeostasis partly depends on the fine regulation of proteolytic activities. We examined the expression of human
cysteine cathepsins (Cats) and their relative contribution to TGF-β1-induced fibroblast differentiation into myofibroblasts. Assays were conducted using both primary fibroblasts obtained from patients with
idiopathic pulmonary fibrosis and human lung CCD-19Lu fibroblasts. Pharmacological inhibition and genetic silencing of Cat B diminished α-smooth muscle actin expression, delayed fibroblast differentiation, and led to an accumulation of intracellular 50-kDa TGF-β1. Moreover, the addition of Cat B generated a 25-kDa mature form of TGF-β1 in Cat B
siRNA-pretreated lysates. Inhibition of Cat B decreased Smad 2/3 phosphorylation but had no effect on
p38 MAPK and JNK phosphorylation, indicating that Cat B mostly disturbs TGF-β1-driven canonical Smad signaling pathway. Although
mRNA expression of
cystatin C was stable, its secretion, which was inhibited by
brefeldin A, increased during TGF-β1-induced differentiation of
idiopathic pulmonary fibrosis and CCD-19Lu fibroblasts. In addition,
cystatin C participated in the control of extracellular Cats, because its gene silencing restored their proteolytic activities. These data support the notion that Cat B participates in lung myofibrogenesis as suggested for stellate cells during
liver fibrosis. Moreover, we propose that TGF-β1 promotes
fibrosis by driving the effective
cystatin C-dependent inhibition of extracellular matrix-degrading Cats.